ArticleHealth science reports2026
Evaluation of the Complete Blood Count (CBC) Parameters in Patients With Hidradenitis Suppurativa and Their Correlation With Disease Severity: A Cross-Sectional Study.
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aim: Hidradenitis suppurativa is a chronic inflammatory skin disease characterized by painful, recurrent lesions most commonly affecting the axillary, groin, and inframammary areas. This study aimed to evaluate CBC parameters in HS patients and analyze their correlation with disease severity to identify potential biomarkers of systemic inflammation. Methods: The current cross-sectional study compared 75 diagnosed HS patients with 75 healthy individuals. CBC parameters included WBC count, RBC count, platelet count, and their respective derived ratios: NLR and PLR. The severity of HS was assessed by SAHS scores and staging of the disease. The various blood markers were compared across groups and analyzed for correlations among each other, the disease severity and stage, and demographic factors. Results: As for the CBC parameters in HS patients as compared with healthy controls, the following were the levels expressed in the study: higher RBC, higher platelets and mean platelet volume or MPV, besides lowered parameters of red blood cell distribution width or RDW, mean corpuscular volume or MCV and mean corpuscular hemoglobin or MCH with corresponding Conclusion: Specifically, the CBC parameters of RBC, RDW, MCV, and MCH were significantly different in HS patients and may thus represent more accessible markers of inflammation and activity. This study sets a promising role for CBC markers in the personalization of care in HS but confirmation of their value in larger populations is still needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.